Word

TALPROXAD

Status

Dead

Status Code

710

Status Date

Friday, July 5, 2024

Serial Number

87457055

Registration Number

5359563

Registration Date

Tuesday, December 19, 2017

Mark Type

4

Filing Date

Friday, May 19, 2017

Published for Opposition

Tuesday, October 3, 2017

Cancellation Date

Friday, July 5, 2024

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events

Aug 21, 2017

Approved For Pub - Principal Register

Sep 13, 2017

Notification Of Notice Of Publication E-Mailed

Oct 3, 2017

Published For Opposition

Oct 3, 2017

Official Gazette Publication Confirmation E-Mailed

May 23, 2017

New Application Entered

May 25, 2017

New Application Office Supplied Data Entered

Aug 16, 2017

Assigned To Examiner

Dec 19, 2017

Registered-Principal Register

Nov 9, 2022

Teas Change Of Correspondence Received

Nov 9, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 9, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 9, 2022

Teas Change Of Owner Address Received

Nov 9, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Dec 19, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jul 5, 2024

Cancelled Sec. 8 (6-Yr)